glp-1 updates GLP-1s are no longer the "future" of diabetes care. They're the present now that 23% of first-line diabetes treatment are GLP-1s. --- In just five years, GLP-1s have gone from niche second-line… 📢 New Resource Alert! We've

The serum nourishes, hydrated whitening and lightening your skin with illuminator action

When the concentrations of sitagliptin were 4, 5, 10, 15, and 20 g/ml, the absorbance concentration plot was rectilinear

Effects of cotadutide on metabolic and hepatic parameters in adults with overweight or obesity and type 2 diabetes: A 54-week randomized phase 2b study

Uses Ipamorelin has been used by athletes as a performance enhancing drug

Prioritize 7 to 9 hours of quality sleep

In early February 2026, Novo Nordisk decided to rename the R2 formulation to the Ozempic Pill, which will be available in the second quarter of the year